CONTACT US LinkedIn Icon

About Kowa Pharmaceuticals America, Inc.

Kowa Pharmaceuticals America, Inc.

Kowa Pharmaceuticals America, Inc., headquartered in Montgomery, Alabama, is committed to continuing the development and commercialization of safe, effective healthcare solutions primarily in the area of cardiometabolic diseases. Established in September 2008, Kowa Pharmaceuticals America focuses its efforts on the successful commercialization of its current and near-term portfolio of pharmaceutical products and business development activities.

Kowa Company, Ltd.

Kowa Company, Ltd., is a privately held, multinational company headquartered in Nagoya, Japan. Established in 1894, Kowa is actively engaged in various manufacturing and trading activities in the fields of pharmaceuticals, life science, information technology, textiles, machinery and various consumer products. Kowa's pharmaceutical division is focused on research and development for cardiovascular therapeutics (dyslipidemia, type 2 diabetes and atherosclerosis), ophthalmology and anti-inflammatory agents. The company’s flagship product, LIVALO® (pitavastatin), is approved in 45 countries around the world.

Meet Our Management Team

The Kowa Pharmaceuticals America, Inc. management team is comprised of individuals dedicated to innovation, consistency and quality, all in service of the physicians and patients who rely on our products.

Meet Our Board of Directors

The following individuals share a vision and pragmatism that ensure the stable and sustained growth of Kowa Pharmaceuticals America, Inc.

  • Ben Stakely Chairman, Chief Executive Officer and President Kowa Pharmaceuticals America, Inc.
  • SHIGERU KIMURA Representative Director Executive Vice President Kowa Company, Ltd.
  • HITOSHI KINOUCHI Chief Manager International Business Marketing Department (Ethical Products) Pharmaceutical Division Kowa Company, Ltd.
  • Craig Sponseller, MD Chief Medical Officer Kowa Pharmaceuticals America, Inc.
  • Takanori Yokoi Executive Officer General Manager of Fuji Factory Pharmaceutical Division Kowa Company, Ltd.
  • Tadashi Edamatsu Business Coordination Director Kowa Pharmaceuticals America, Inc.
  • SAKIKO KANEDA Department Manager Americas Section, Europe/Americas Sales & Marketing Department Pharmaceutical Division Kowa Company, Ltd.